4Vincent L,Kermani P,Young LM,et al.Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling[J].J Clin Invest,2005,115(11):2 993.
5Ahmed B,Van Eijk LI,Bouma-Ter SJC,et al.Vascular targeting effect of combretastatin A-4 phosphate dominates the inherent angiogenesis inhibitory activity[J].Int J Cancer,2003,105(1):20.
6Dowlati A,Robertson K,Cooney M,et al.A phase Ⅰ pharmacokinetic and translational study of the novel vascular targeting agent combretastatin A-4 phosphate on a single dose intravenous schedule in patients with advanced cancer[J].Cancer Res,2002,62(12):3 408.
7Rustin GJ,Galbraith SM,Anderson H,et al.Phase Ⅰ clinical trial of weekly combretastatin A4 phosphate:clinical and pharmacokinetic results[J].J Clin Oncol,2003,21(15):2 815.
8Galbraith SM,Maxwell RJ,Lodge MA,et al.Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging[J].J Clin Oncol,2003,21(15):2 831.
9Stevenson JP,Rosen M,Sun W,et al.Phase Ⅰ trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer:magnetic resonance imaging evidence for altered tumor blood flow[J].J Clin Oncol,2003,21(23):4 428.
6West CML, Price P. Combretastatin A4 phosphate [J]. Anti - Cancer Drugs, 2004,15 ( 3 ) : 179 - 187.
7Lin CM, Ho HH, Pettit GR, et al. Antimitotic natural products combretastatin A -4 and combrestastatin A -2: studies on the mechanism of their ingibition of the binding of colchicine to tubulin[ J]. Biochemistry , 1989,28:6984 - 6991.
